The prevalence of antibiotic resistance of Enterobacteriaceae strains isolated in community- and Hospital-acquired infections in teaching hospitals of Hamadan, west of Iran

Journal of Research in Health Sciences

Volumn 13, Issue 1, 2013, Pages 75-80

  Hashemi, Seyyed Hamid ^a   Esna Ashari, Farzaneh ^a   Tavakoli, Shahrzad ^a   Mamani, Mojgan ^a  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antimicrobial resistance; Enterobacteriaceae; Nosocmial infection

Indexed keywords

AMIKACIN; AMPICILLIN; CEFAZOLIN; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; PIPERACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CITROBACTER; COMMUNICABLE DISEASE; COMPARATIVE STUDY; DEMOGRAPHY; DESCRIPTIVE RESEARCH; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HOSPITAL INFECTION; IRAN; KLEBSIELLA PNEUMONIAE; MEDICAL RECORD REVIEW; MORGANELLA; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; PROTEUS; QUESTIONNAIRE; SALMONELLA; SERRATIA; TEACHING HOSPITAL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES;

COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALS, TEACHING; HUMANS; IRAN; MICROBIAL SENSITIVITY TESTS; PREVALENCE;

EID: 84879248289     PISSN: 16822765     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Brooks GF, Carroll KC, Butel JS, Morse SA. Jawetz, Melnick & Adelberg'sMedical Microbiology. 24th ed. New York: McGraw-Hill; 2007.
2. Coello R, Gastmeier P, de Boer AS. Surveillanceofhospital-acquiredinfectioninEng-land,Germany,andTheNetherlands:willinternationalcompari sonofratesbepossible? Infect Control Hosp Epidemiol. 2001; 22:393-397.
3. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. Clin Infect Dis. 1999; 29:490-494
4. Vayalumkal JV, Streitenberger L, Wray R, Goldman C,Freeman R, Drews Set al.Survey of isolation practices at a tertiary care pediatric hospital. Am J Infect Control. 2007;35:207-211.
5. Aminzadeh Z, Zare-Dehabadi M, Gachkar L, Shah-Hoseini H. Frequency of gram-negative bacilli and their antimicro- bial resistance patterns in Loghman Hospital. Iran J Infect Trop Dis. 2006; 10:27-33.
6. Hashemi SH, Mamani M, Jamal-Omidi S, Niayesh A. Nos-ocomial bacterial infections and their antimicrobial re- sistance patterns in university hospitals of Hamadan, Iran. J Res Health Sci. 2010;10(1):54-58.
7. Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott's Di-agnostic Microbiology. 12th ed. Philadelphia: Elsevier Mosby; 2007.
8. CLSI. Performance standards for antimicrobial susceptibil-ity testing. 18th informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
9. Ducel G, Fobry J, Nicolle L. Prevention of hospital-cquired infections: a practical guide. 2nded, Geneva: WHO; 2002
10. Hadadi A, Rasoulinejad M, Maleki Z, Yonesian M, Shirani A, Kourorian Z. Antimicrobial resistance pattern of gram- negative bacilli of nosocomial origin at 2 university hospi- tal in Iran. Diagn Microbiol Infect Dis. 2008;60:301-305
11. Shanthi M, Sekar U. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.J Assoc Physicians India. 2010;58 Suppl:41-44.
12. Kunz AN, Brook I. Emerging resistant gram-negative aero- bic bacilli in hospital-acquired infections. Chemotherapy 2010;56:492-500.
13. Tsay R, Siu LK, Fung CP, Chang FY. Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection. Arch Intern Med. 2002;162:1021-1027.
14. Yinnon AM, Butnaru A, Raveh D, Jerassy Z, Rudensky B. Klebsiella bacteraemia: community versus nosocomial in- fection. QJM. 1996; 89:933-941.
15. Wang Z, Ji W, Guo HB, Tao YZ, Ding YF. Comparative studies on the composition and antibiotic-resistance of pathogenic bacteria between children with community- acquired and hospital-acquired pneumonia. Zhonghua Yu Fang Yi Xue Za Zhi. 2011;45:211-216.
16. Kang CI, Kim SH, Bang JW, Kim HB, Kim NJ, Kim EC, et al. Community-acquired versus nosocomial klebsiella pneumonia bacteremia: clinical features, treatment out- comes, and clinical implication of antimicrobial resistance.J Korean Med Sci. 2006;21:816-822.
17. Cagnacci S, Gualco L, Debbia E, Schito GC, Marchese A. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 caus- ing community-acquired uncomplicated cystitis. J Clin Mi- crobiol. 2008;46:2605-2612.
18. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D et al. Community and hospital spread of Esch- erichia coli producing CTX-M extended-spectrum b- lactamases in the UK. J Antimicrobial Chemother 2004;54:735-743.
19. Tsai SS, Huang JC, Chen ST, Sun JH, Wang CC, Lin SF, et al. Characteristics of Klebsiella pneumoniae bacteremia in community-acquired and nosocomial infections in diabetic patients.Chang Gung Med J. 2010;33:532-539.
20. Wollheim C, Guerra IM, Conte VD, Hoffman SP, Schreiner FJ, Delamare AP, et al. Nosocomial and community infec- tions due to class A extended-spectrum β-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil. Braz J Infect Dis.2011;15(2):138-143
21. Pitout JD, Laupland KB. Extended-spectrum β-lactamase- producing enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis.2008;8:159-166.
22. Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Cantón R, Baquero F. Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended- spectrum-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 study for monitoring antimicrobial resistance trends. Anti- microb Agents Chemother 2010;54:3043-3046.
23. Pitout JD. Infections with extended-spectrum beta- lactamase-producing enterobacteriaceae: changing epide- miology and drug treatment choices. Drugs. 2010;70:313-333.
24. Feizabadi MM, Etemadi G, Yadegarinia D, Rahmati M, Shabanpoor S, Bokaei S. Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran.Med Sci Monit. 2006;12(11):362-365.
25. Mirsalehian A, Akbari Nakhjavani F, Peymani A.,Jabal Ameli Fereshteh,Mirafshar S.M.,Hamidian M. Frequency of extended spectrum b-lactamase producing Enterobacteri- aceae in intensive care units. Tehran University Medical Journal. 2007;65(1):33-38.
26. Bazzaz BS, Naderinasab M, Mohamadpoor AH, Far- shadzadeh Z, Ahmadi S, Yousefi F. The prevalence of ex- tended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran.Acta Microbiol Immunol Hung. 2009;56(1):89-99.
27. Mansouri S, Abbasi S. Prevalence of multiple drug resistant clinical isolates of extended-spectrum beta- lactamase pro- ducing Enterobacteriaceae in Southeast Iran. Iran J Med Sci. 2010;35(2):101-108.
28. Khourshidi A, Sharif AR. Imipenem resistance among gram-negative and gram-positive bacteria in hospitalized patients. Iranian J Publ Health 2010;39(2):110-113
29. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem- resistant Enterobacteriaceae:epidemiology and prevention. Clin Infect Dis. 2011;53(1):60-67.
30. Benwan K, Sweih N, Rotimi VO. Etiology and antibiotic susceptibility patterns of community- and hospital-acquired urinary tract infections in a general hospital in Kuwait. Med Princ Pract. 2010;19:440-446.
31. Khanfar HS, Bindayna KM, Senok AC, Botta GA. Extend- ed spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings. J Infect Dev Ctries.2009; 3:295-299
32. Sire JM, Nabeth P, Perrier-Gros-Claude JD, Bahsoun I, Siby T, Macondo EA, et al. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Sene- gal. J Infect Dev Ctries. 2007;1(3):263-268.
33. Dimitrov TS, Udo EE, Emara M, Awni F, Passadilla R. Etiology and Antibiotic Susceptibility Patterns of Commu- nity-Acquired Urinary Tract Infections in a Kuwait Hospi- tal. Med Princ Pract. 2004;13:334-339.
34. Arredondo-García JL, Amábile-Cuevas CF. High resistance prevalence towards ampicillin, co-trimoxazole and ciprof- loxacin, among uropathogenic Escherichia coli isolates in Mexico City. J Infect Developing Countries. 2008;2:350-353.
35. Randrianirina F, Soares JL, Carod JF, Ratsima E, Thonnier V, Combe P, et al. Antimicrobial resistance among uro- pathogens that cause community-acquired urinary tract in- fections in Antananarivo, Madagascar. J Antimicrob Chemother 2007;59:309-312.
36. Bours PHA, Polak R, Hoepelman AIM, Delgado E, Jarquin A, Matute AJ. Increasing resistance in community-acquired urinary tract infections in Latin America, five years after the implementation of national therapeutic guidelines. Int J Infect Dis. 2010;14:e770-e777.